- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02509832
COOL AMI EU Pilot Trial to Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction
COOL-AMI EU PILOT TRIAL: A Multicenter, Prospective, Randomized Controlled Trial To Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With ACUTE MYOCARDIAL INFARCTION
COOL AMI EU Pilot Trial: A Multicenter, Prospective, Randomized Controlled Trial to Assess Cooling as an adjunctive Therapy to Percutaneous Intervention in Patients with Acute Myocardial Infarction.
Evaluate the retention of subjects after integrating therapeutic hypothermia using the ZOLL Proteus IVTM System into existing STEMI treatment protocols for subjects who present with acute anterior myocardial infarction.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria
- Universitätsklinik für Notfallmedizin Allgemeines Krankenhaus der Stadt Wien
-
-
-
-
-
Tallinn, Estonia, 13419
- North Estonia Medical Center
-
-
-
-
-
Balatonfüred,, Hungary, 8230
- Heart Center Balatonfüred
-
Debrecen, Hungary, 4032
- Medical and Health Science Center University of Debrecen
-
Pecs, Hungary, H-7624
- Heart Institute University of Pecs
-
-
-
-
-
Warsaw, Poland, 04628
- National Institute of Cardiology, Department of Interventional Cardiology & Angiology
-
Zabrze, Poland, 41-800
- Silesian Center for Heart Diseases
-
Łódź, Poland
- Medical University in Łódź, Bieganski Hospital
-
-
-
-
-
Belgrade, Serbia
- Clinical Center of Serbia Head of Department for invasive diagnostics (Division of Cardiology)
-
Zemun, Serbia
- University Clinical Hospital Center Zemun
-
-
-
-
-
Ljubljana, Slovenia, 1000
- University Medical Centre Ljubljana
-
-
-
-
-
Lund, Sweden
- Skane University Hospital Lund University
-
-
-
-
Essex
-
Basildon, Essex, United Kingdom
- Essex Cardiothoracic Centre, Anglia Ruskin University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
All Inclusion Criteria must be answered YES for subject to be eligible for trial Inclusion Criteria:
- ≥ 18 years of age.
- symptoms consistent with AMI (chest pain, unresponsive to nitroglycerin, ≥ 30 minutes and < 6 hours.
- Anterior MI with ST-segment elevation of 0.2 mV in two or more anterior contiguous precordial leads.
- Eligible for PCI.
- Opportunity for at least 10 minutes of cooling with the Proteus IVTM System prior to PCI.
- Written, informed consent to participate in this clinical trial.
Exclusion Criteria:
All Exclusion Criteria must be answered NO for subject to be eligible for trial inclusion.
- Previous myocardial infarction.
- Cardiogenic shock (systolic blood pressure [SBP] <80 mmHg and non-responsive to fluids, or SBP <100 mmHg with vasopressors, or requirement for an intra-aortic balloon pump [IABP]).
- Resuscitated cardiac arrest, atrial fibrillation, or Killip risk stratification class II through IV
- Aortic dissection or requires an immediate surgical or procedural intervention other than PCI
- Congestive Heart Failure (CHF), hepatic failure, end- stage kidney disease or severe renal failure (clearance < 30ml/min/1.73m2).
- Fever (temperature > 37.5 °C) or infection with fever in the last 5 days.
- Previous CABG.
- Stroke within 90 days of admission.
- Cardio-pulmonary decompensation present or imminent
- Contraindications to hypothermia, such as patients with known hematologic dyscrasias which affect thrombosis (e.g., cryoglobulinemia, sickle cell disease, serum cold agglutinins) or vasospastic disorders (such as Raynaud's or thromboangitis obliterans)
- Hypersensitivity or contraindication to aspirin, heparin, or sensitivity to contrast media, which cannot be adequately pre-medicated.
- History of bleeding diathesis, coagulopathy, cryoglobulinemia, sickle cell anemia, or will refuse blood transfusions.
- Height of <1.5 meters (4 feet 11 inches).
- Hypersensitivity to buspirone hydrochloride or Pethidine (Meperidine) and/or treatment with a monoamine oxidase inhibitor in the past 14 days.
- History of severe hepatic or renal impairment, untreated hypothyroidism, Addison's disease, benign prostatic hypertrophy, or urethral stricture that in the opinion of the physician would be incompatible with Pethidine administration.
- Inferior Vena Cava filter in place (IVC).
- The patient has a pre-MI life expectancy of <1 year due to underlying medical conditions or pre-existing co-morbidities.
- Known, unresolved history of drug use or alcohol dependency, or lacks the ability to comprehend or follow instructions.
- Currently enrolled in another investigational drug or device trial that has not completed the primary endpoint.
- Apprehension or unwilling to undergo the required MRI imaging at follow-up, has a documented or suspected diagnosis of claustrophobia, or has Gadolinium allergy
- Received thrombolytic therapy en route to the hospital
- Clinical evidence of spontaneous reperfusion as observed symptomatically and/ or from ECG findings (partial or complete ST resolution in ECG before randomization) upon admission
- Vulnerable subject, for instance, a person in detention (i.e., prisoner or ward of the state)
- Female who is known to be pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Cooling + PCI
The subjects will be considered to be enrolled in the Test Arm of the trial when all inclusion and exclusion criteria have been met, the informed consent form has been signed, and randomization to the Test Arm of the trial to allow cooling with the Proteus IVTM System before and after PCI.
|
Cooling with ZOLL Proteus IVTM System before and after Percutaneous Coronary Intervention (PCI)
|
OTHER: PCI only
The subjects will be considered to be enrolled in the Control Arm of the trial when all inclusion and exclusion criteria have been met, the informed consent form has been signed, and randomization to the Control Arm of the trial to allow PCI only.
|
Standard of Care for PCI
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportion of all subjects who complete the follow-up and cMR imaging requirements at 30-day follow up period
Time Frame: 30 day
|
30 day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
1. Anterior Infarct Size (IS) as assessed by Cardiac Magnetic Resonance (cMR) at 4 - 6 days following the index procedure for subjects in Test and Control Arms
Time Frame: 4 - 6 days
|
4 - 6 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Holzer, Universitätsklinik für Notfallmedizin Allgemeines Krankenhaus der Stadt Wien
- Principal Investigator: Marko Noc, University Medical Center Ljubljana Slovenia
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EDC-2420
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Myocardial Infarction
-
Henry Ford Health SystemAbiomed Inc.Enrolling by invitationAcute Myocardial Infarction | Cardiogenic Shock | STEMI | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial Infarction | NSTEMI | Acute Myocardial Infarction With ST Elevation | Acute Myocardial Infarction of Right Ventricle (Disorder) | Acute Myocardial Infarction of Left VentricleUnited States
-
Jordan Collaborating Cardiology GroupCardiovascular Academy GroupTerminatedTriggers of Acute Myocardial Infarction | Time of Onset of Acute Myocardial Infarction | Long-term Prognosis After Acute Myocardial InfarctionJordan
-
Recardio, Inc.CompletedAcute Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Myocardial IschemiaNetherlands, Hungary, Austria, Poland, Belgium
-
Medical Center of South ArkansasWithdrawnAcute Coronary Syndrome | Acute ST Segment Elevation Myocardial InfarctionUnited States
-
Yuan's General HospitalKaohsiung Veterans General Hospital.; Sin-Lau HospitalUnknownAcute Myocardial Infarction, of Inferolateral Wall | Acute Myocardial Infarction, of Inferoposterior WallTaiwan
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Acute Coronary Syndrome | Acute Myocardial Infarction | Metabolic DisturbanceGreece
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
Sheba Medical CenterCompletedNon ST Elevation Myocardial Infarction | Acute Coronary SyndromesIsrael
-
Medstar Health Research InstituteWithdrawnST-elevation Myocardial Infarction | Acute Myocardial InfarctionUnited States
-
Hennepin Healthcare Research InstituteSiemens HealthineersActive, not recruitingAcute Coronary Syndrome | Acute Myocardial InfarctionUnited States
Clinical Trials on Cooling + PCI
-
ZOLL Circulation, Inc., USAUnknown
-
State University of New York at BuffaloCompleted
-
University of Mississippi Medical CenterNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...Jinhua People's Hospital; Jinhua Municipal Central Hospital; Yiwu Central Hospital and other collaboratorsRecruiting
-
VA Office of Research and DevelopmentNot yet recruitingSpinal Cord InjuriesUnited States
-
The Cleveland ClinicCompleted
-
Indonesia UniversityCompletedHeart; Surgery, Heart, Functional Disturbance as ResultIndonesia
-
Robertson, Nicola, M.D.Thayyil, SudhinUnknown
-
University of OttawaRecruitingHyperthermia | Aging | Heat Stress | CoolingCanada
-
Massachusetts General HospitalActive, not recruiting